Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia
Open Access
- 25 April 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 117 (2) , 390-398
- https://doi.org/10.1046/j.1365-2141.2002.03455.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 2000
- Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1Nature Genetics, 2000
- Familial Dominant Thrombocytopenia: Clinical, Biologic, and Molecular StudiesPediatric Research, 1999
- An Autosomal Dominant Thrombocytopenia Gene Maps to Chromosomal Region 10pAmerican Journal of Human Genetics, 1999
- A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for transfusion purposesBritish Journal of Haematology, 1999
- Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopeniaBone Marrow Transplantation, 1998
- X-Linked Wiskott–Aldrich Syndrome in a GirlNew England Journal of Medicine, 1998
- Defective response to thrombopoietin and impaired expression of c‐mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 1997
- Serum thrombopoietin and plasma glycocalicin concentrations as useful diagnostic markers in thrombocytopenic disordersEuropean Journal of Haematology, 1996
- Congenital Amegakaryocytic ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1990